Health Industry Watch
SEE OTHER BRANDS

Your healthcare and wellness news reporter

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on July 31, 2025

MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million

MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million

LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces a Standby …

A novel therapy eradicates triple negative breast cancer recurrence in preclinical models

A novel therapy eradicates triple negative breast cancer recurrence in preclinical models

The results achieved by Cima Universidad de Navarra show that ENPP1 blockade increases the efficacy of radiotherapy abrogating the primary tumor and metastases PAMPLONA, SPAIN, July 31, 2025 /⁨EINPresswire.com⁩/ -- A study conducted by scientists at the …

Wearable Healthcare Devices Market Size to Reach USD 137.40 Billion by 2034, Growing at 11.20% CAGR

Wearable Healthcare Devices Market Size to Reach USD 137.40 Billion by 2034, Growing at 11.20% CAGR

The global wearable healthcare devices market was valued at approximately USD 47.53 billion in 2024 and is expected to reach around USD 137.40 billion by 2034 PUNE, MAHARASHTRA, INDIA, July 31, 2025 /⁨EINPresswire.com⁩/ -- Executive Summary: The global …

Voices Across the Network: Men’s Health Month 2025 Fueled by Community-Led Momentum

Voices Across the Network: Men’s Health Month 2025 Fueled by Community-Led Momentum

Digital media and in-person campaigns centered around Men's Health Month in June of 2025 were a huge success and reported on herein. WASHINGTON, DC, UNITED STATES, July 31, 2025 /⁨EINPresswire.com⁩/ -- As Men’s Health Month 2025 ends, Men’s Health Network …

Gene Therapy Market Fueled by CRISPR Advances & Regulatory Momentum | DataM Intelligence

Gene Therapy Market Fueled by CRISPR Advances & Regulatory Momentum | DataM Intelligence

Gene therapy market surges on breakthroughs in genome editing, rising chronic …

NFEC Urges MAHA Movement: Address Financial Instability to Make America Healthy Again

NFEC Urges MAHA Movement: Address Financial Instability to Make America Healthy Again

WASHINGTON DC, DC, UNITED STATES, July 31, 2025 /⁨EINPresswire.com⁩/ -- The National Financial Educators Council (NFEC) is launching a bold, nationwide initiative to formally classify financial instability as a Public Health Emergency (PHE)—warning that …

Cavo Health’s Precise Word Matching AI Delivers Unmatched Accuracy and ROI for Payers in Risk Adjustment Coding

Cavo Health’s Precise Word Matching AI Delivers Unmatched Accuracy and ROI for Payers in Risk Adjustment Coding

Outperforms Machine Learning Tools with 96%+ HCC completeness, 2–4x Productivity Gains and Reduced Audit Risk INDIANAPOLIS, IN, UNITED STATES, July 31, 2025 /⁨EINPresswire.com⁩/ -- Cavo Health, a US-based healthcare technology company, is redefining risk …

Dermasurge Clinic Introduces Advanced Laser and Skin Treatments in Harley Street

Dermasurge Clinic Introduces Advanced Laser and Skin Treatments in Harley Street

Dermasurge Clinic (LSE:DS) LONDON, LONDON, UNITED KINGDOM, July 31, 2025 /⁨EINPresswire.com⁩/ -- Renowned Consultant Dermatologist Dr Hiba Injibar is proud to offer world-class skin care services at her advanced private dermatology practice, Dermasurge …

VedTechBio पेश करता है, नेक्स्ट जेन ड्रग डिस्कवरी एआई; मल्टीथेरेपी कोलेबोरेशन के तौर पर AlphaMeld के साथ साझेदारी मे…

VedTechBio पेश करता है, नेक्स्ट जेन ड्रग डिस्कवरी एआई; मल्टीथेरेपी कोलेबोरेशन के तौर पर AlphaMeld के साथ साझेदारी मे…

BENGALURU, India, Aug. 01, 2025 (GLOBE NEWSWIRE) -- VedTechBio Research Pvt. Ltd., एआई-संचालित औषधि खोज में अग्रणी संगठन, ने आज अपने RxAgentAI™ प्लेटफॉर्म में प्रमुख संवर्द्धन की घोषणा की, जिससे औषधि खोज की समय-सीमा आधी रह गई, साथ ही मेटाबोलिक और दुर्लभ …

Dr. Mohana Rao Patibandla Named Best Neurosurgeon in India at ET Health Conclave 2025

Dr. Mohana Rao Patibandla Named Best Neurosurgeon in India at ET Health Conclave 2025

Honored as Best Spine Surgeon and Minimally Invasive Neurosurgeon by The Economic Times Health Awards GUNTUR, ANDHRA PRADESH, INDIA, July 31, 2025 /⁨EINPresswire.com⁩/ -- At the prestigious ET Health Conclave 2025, held at the Grand Hyatt, Gurgaon, Dr. …

TD Vaccine Market Attaining USD 8.67 Billion till 2032, at a CAGR of 5.2% from 2025 to 2032

TD Vaccine Market Attaining USD 8.67 Billion till 2032, at a CAGR of 5.2% from 2025 to 2032

The TD Vaccine Market size was valued at USD 5.78 Bn. in 2024 is expected to grow at a CAGR of 5.2% from 2025 to 2032, reaching nearly USD 8.67 Bn. by 2032 SAVANNAH, GA, UNITED STATES, July 31, 2025 /⁨EINPresswire.com⁩/ -- Stellar Market Research examines …

Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Coherus, Coherus Oncology or the Company, Nasdaq: CHRS), today announced that its second quarter 2025 financial results will be released after market close on Thursday, August …

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Announces Q2-2025 Shareholder Update Call

NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00 PM ET. The call will include updates on all of the …

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental …

Thérapeutique Knight annonce la soumission réglementaire supplémentaire de MINJUVI® (tafasitamab) pour le traitement du lymphome folliculaire au Brésil

Thérapeutique Knight annonce la soumission réglementaire supplémentaire de MINJUVI® (tafasitamab) pour le traitement du lymphome folliculaire au Brésil

MONTRÉAL, 31 juill. 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd’hui que sa filiale brésilienne, United Medical Ltda, a soumis une demande …

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …

Self-Administered Medication Market is Expected to Reach a Valuation of USD 256.7 Billion by 2035, Fact.MR Analysis

Self-Administered Medication Market is Expected to Reach a Valuation of USD 256.7 Billion by 2035, Fact.MR Analysis

Exploring growth, innovation, and key trends shaping the global self-administered medication market across product types, applications, and regions. ROCKVILLE, MD, UNITED STATES, July 31, 2025 /⁨EINPresswire.com⁩/ -- The global self‑administered …

Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025

Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025

LEXINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and …

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

RADNOR, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer. In this role, Bouton will lead …

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

BALA CYNWYD, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of its previously …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions